|
From the Wandsworth Primary Care Research Centre, Wandsworth Primary Care Trust (Millett, Gray); and the Department of Primary Care and Social Medicine, Imperial College Faculty of Medicine (Millett, Saxena, Netuveli, Majeed), London, England.
Correspondence to: Christopher Millett, Specialist Trainee in Public Health, Department of Primary Care and Social Medicine, 3rd floor, Reynolds Building, Imperial College Faculty of Medicine, St Dunstan's Road, London UK W6 8RP; fax 44 20 7594 0866; c.millett{at}imperial.ac.uk
Background: Many people with diabetes continue to smoke despite being at high risk of cardiovascular disease. We examined the impact of a pay-for-performance incentive in the United Kingdom introduced in 2004 as part of the new general practitioner contract to improve support for smoking cessation and to reduce the prevalence of smoking among people with chronic diseases such as diabetes.
Methods: We performed a population-based longitudinal study of the recorded delivery of cessation advice and the prevalence of smoking using electronic records of patients with diabetes obtained from participating general practices. The survey was carried out in an ethnically diverse part of southwest London before (JuneOctober 2003) and after (November 2005January 2006) the introduction of a pay-for-performance incentive.
Results: Significantly more patients with diabetes had their smoking status ever recorded in 2005 than in 2003 (98.8% v. 90.0%, p <0.001). The proportion of patients with documented smoking cessation advice also increased significantly over this period, from 48.0% to 83.5% (p < 0.001). The prevalence of smoking decreased significantly from 20.0% to 16.2% (p < 0.001). The reduction over the study period was lower among women (adjusted odds ratio 0.71, 95% confidence interval 0.530.95) but was not significantly different in the most and least affluent groups. In 2005, smoking rates continued to differ significantly with age (10.6%25.1%), sex (women, 11.5%; men, 20.6%) and ethnic background (4.9%24.9%).
Interpretation: The introduction of a pay-for-performance incentive in the United Kingdom increased the provision of support for smoking cessation and was associated with a reduction in smoking prevalence among patients with diabetes in primary health care settings. Health care planners in other countries may wish to consider introducing similar incentive schemes for primary care physicians.
Related Articles
This article has been cited by other articles:
![]() |
E. Koshy and C. Millett The 'Quality and Outcomes Framework': improving care, but are all patients benefiting? J R Soc Med, September 1, 2008; 101(9): 432 - 433. [Full Text] [PDF] |
||||
![]() |
W. P. Wodchis, J. S. Ross, and A. S. Detsky Is P4P Really FFS? JAMA, October 17, 2007; 298(15): 1797 - 1799. [Full Text] [PDF] |
||||
![]() |
C. M. Bell and W. Levinson Pay for performance: learning about quality Can. Med. Assoc. J., June 5, 2007; 176(12): 1717 - 1719. [Full Text] [PDF] |
||||
Read all eLetters